Reactivation of herpesvirus infections after vaccinations?

Walter, Roland; Hartmann, Katharina; Fleisch, Felix; Reinhart, Walter H.; Kuhn, Max

doi:10.1016/s0140-6736(99)00623-6

Cited by 97 publications

(98 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The increase in premalignant cell changes in non-naïve individuals, as suggested by the FDA, is consistent with the knowledge that vaccination can cause reactivation of both target and non-target viruses (6)(7)(8)(9)(10)(11)(12). For Gardasil, the HPV types 16 and 18 are called target HPVs since the vaccine contains antigens for these two HPV types.…”

Section: R E T R a C T E Dsupporting

confidence: 81%

RETRACTION: Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination

2018

IJME

View full text Add to dashboard Cite

The comment "Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination" (DOI: 10.20529/IJME.2018.037) was published online in the Indian Journal of Medical Ethics on April 30, 2018. The author gave his name and affiliation as Lars Andersson, department of Physiology and Pharmacology, Karolinska Institutet (KI), Sweden. On May 8, as soon as KI informed us that no such person worked there, we carried out a correction on the same day and the institution's name was removed as affiliation.

show abstract

Section: R E T R a C T E Dsupporting

confidence: 81%

RETRACTION: Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination

2018

IJME

View full text Add to dashboard Cite

show abstract

“…It is considered that vaccine-related immunomodulation including suppression of cellular immunity by live attenuated vaccines and attenuated alloreactivity caused by inactivated hepatitis B vaccine may be responsible for the reactivation of herpes virus infections. 9,10 To our knowledge, this is the first case of VZV reactivation following COVID-19 vaccination. Even though it is not possible to establish F I G U R E 1 Dermatological examination showed some crusted, hemorrhagic vesicles upon an erythematous base occupying an area corresponding to T3-T4 dermatomes on the chest (A) and the back (B)…”

Section: Covid-19mentioning

confidence: 80%

Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence?

Bostan

Yalıcı-Armağan

2021

J of Cosmetic Dermatology

116

120

View full text Add to dashboard Cite

a straightforward relationship between herpes zoster and inactivated COVID-19 vaccine, immune dysregulation created by the vaccine may play a role in the reactivation of latent VZV infection in the current case. COVID-19 pandemic seems to be a favorable period for large-scale epidemiological studies to elucidate the relationship between the vaccination and herpes zoster reactivation due to planned massive vaccination.

show abstract

“…Authors have postulated that immunomodulatory effects of the Covid-19 vaccines may have promoted zoster reactivation, 28 , 29 as has been demonstrated with prior vaccines. 39 While this temporal association proposes a causal relationship, the concomitant use of immunosuppressive therapies and coexisting comorbidities in select patients confounds this assessment. Further studies that enable incidence measurements may more clearly delineate a mechanism for these findings.…”

Section: Rarely-reported Cutaneous Adverse Eventsmentioning

confidence: 99%

Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!

Gronbeck

Grant‐Kels

2021

Clinics in Dermatology

View full text Add to dashboard Cite

Despite the growing availability of Covid-19 vaccines in the general population, a significant proportion of individuals demonstrate vaccine hesitancy. We sought to consolidate and update current evidence on cutaneous adverse events from Covid-19 vaccines to aid in education and counseling of patients concerned about potential cutaneous side effects. We conducted a literature review of PubMed in May 2021 to identify reports of cutaneous events following the Pfizer-BioNTech and Moderna vaccines (post-authorization clinical reports pertaining to the Johnson and Johnson and AstraZeneca vaccines were limited). Event reports in the Vaccine Adverse Event Reporting System (VAERS) were also reviewed. Localized cutaneous reactions were common following the mRNA vaccines, consistent with clinical trial findings. Reported urticarial and morbilliform eruptions may reflect immediate hypersensitivity but have rarely been associated with anaphylaxis. There are infrequent reports of herpes zoster, dermatologic filler reactions, and immune thrombocytopenia, mainly occurring in high-risk patient groups. Ultimately, the identified cutaneous reactions are largely self-limited and should not discourage vaccination. Existing reports should reassure patients of the overall compelling safety profiles and benignity of skin reactions following the mRNA Covid-19 vaccines.

show abstract

Reactivation of herpesvirus infections after vaccinations?

Cited by 97 publications

References 5 publications

RETRACTION: Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination

RETRACTION: Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination

Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence?

Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!

Contact Info

Product

Resources

About